6H90 Stock Chart & Stats
€0.49
<€0.01(0.25%)
At close: 4:00 PM EDT
€0.49
<€0.01(0.25%)
Day’s Range― - ―
52-Week Range€0.34 - €0.99
Previous CloseN/A
Volume31.00K
Average Volume (3M)1.71K
Market Cap
€151.64M
Enterprise Value€287.49M
Total Cash (Recent Filing)€39.81M
Total Debt (Recent Filing)€84.51M
Price to Earnings (P/E)―
Beta0.80
Next Earnings
Nov 16, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding304,754,880
10 Day Avg. Volume2,824
30 Day Avg. Volume1,705
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.70
Price to Sales (P/S)2.03
P/FCF Ratio-10.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€1.18Price Target Upside140.18% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)-0.03
Revenue Forecast (FY)€84.59M
Bulls Say, Bears Say
Bulls Say
Revenue Scale-UpThe sharp first-half revenue increase shows that the Orion acquisition has materially expanded HEALWELL AI’s operating base and market reach. A larger revenue platform can support broader customer adoption, improve scale economics, and provide a stronger foundation for recurring software growth over the next several quarters.
Platform ScaleCoverage across a large healthcare data and provider ecosystem is a meaningful structural advantage for clinical AI. The scale supports broader validation, strengthens product relevance across workflows, and may make the platform more valuable to enterprise customers seeking analytics with wide clinical reach.
Enterprise Recurring ShiftThe move from smaller pilots toward larger enterprise licenses and cross-selling indicates progress toward a more durable recurring-revenue model. Larger contracts can improve customer depth, revenue visibility, and monetization of the existing Orion base as implementations mature.
Bears Say
Persistent LossesHEALWELL AI has not yet demonstrated consistent profitability or self-funded growth, despite improving results. Persistent losses and negative trailing cash flow can constrain reinvestment flexibility, increase reliance on external funding, and leave execution more exposed if the expected improvement takes longer.
Enterprise Sales DelaysLong enterprise sales cycles create a structural timing risk for a business transitioning toward larger recurring contracts. Delayed decisions and revenue recognition can make growth uneven, defer expected AI and data-science expansion, and complicate planning while the company builds its enterprise pipeline.
Integration ExecutionThe incomplete cost and margin synergy program means a substantial portion of the Orion integration benefits remains dependent on execution. Technology-debt reduction and R&D consolidation are expected to take about 1.5 years, delaying full margin improvement and sustaining pressure on profitability.
HEALWELL AI News
6H90 FAQ
What was HEALWELL AI’s price range in the past 12 months?
HEALWELL AI lowest stock price was €0.34 and its highest was €0.98 in the past 12 months.
What is HEALWELL AI’s market cap?
HEALWELL AI’s market cap is €151.64M.
When is HEALWELL AI’s upcoming earnings report date?
HEALWELL AI’s upcoming earnings report date is Nov 16, 2026 which is in 32 days.
How were HEALWELL AI’s earnings last quarter?
HEALWELL AI released its earnings results on Aug 07, 2026. The company reported €0.013 earnings per share for the quarter, beating the consensus estimate of -€0.016 by €0.028.
Is HEALWELL AI overvalued?
According to Wall Street analysts HEALWELL AI’s price is currently Undervalued.
Does HEALWELL AI pay dividends?
HEALWELL AI does not currently pay dividends.
What is HEALWELL AI’s EPS estimate?
HEALWELL AI’s EPS estimate is -0.02.
How many shares outstanding does HEALWELL AI have?
HEALWELL AI has 304,754,880 shares outstanding.
What happened to HEALWELL AI’s price movement after its last earnings report?
HEALWELL AI reported an EPS of €0.013 in its last earnings report, beating expectations of -€0.016. Following the earnings report the stock price went up 6.5%.
Which hedge fund is a major shareholder of HEALWELL AI?
Currently, no hedge funds are holding shares in DE:6H90
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HEALWELL AI Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-55.26%
12-Months-Change
Fundamentals
Return on Equity
-23.76%
Trailing 12-Months
Asset Growth
-10.58%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
HEALWELL AI
Healwell AI Inc., a Toronto-based healthcare technology firm established in 2012, specializes in leveraging artificial intelligence and data science to advance preventative medical care. The company develops an AI-powered platform designed to assist healthcare providers with crucial decision-making. They maintain a significant strategic partnership with WELL Health Technologies Corp., focusing on accelerating the expansion and innovation of AI-driven healthcare solutions. Prior to its current name, adopted in October 2023, the organization was known as MCI Onehealth Technologies Inc.
6H90 Stock 12 Month Forecast
Average Price Target
€1.18
▲(140.18% Upside)
Technical Analysis
Cardiocomm Solutions
―
Reliq Health Technologies
―
Leveljump Healthcare Corp.
―
Kovo HealthTech Corporation
―
Hydreight Technologies Inc
―